 | Up a level |
Christensen, Emil; Wyatt, Alexander W; Galsky, Matthew D; Grivas, Petros; Seiler, Roland; Nawroth, Roman; Goebell, Peter J; Schmitz-Drager, Bernd J; Williams, Stephen B; Black, Peter C; Kamat, Ashish M; Todenhöfer, Tilman; Dyrskjøt, Lars (2023). IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer. Urologic oncology - seminars and original investigations, 41(7), pp. 318-322. Elsevier 10.1016/j.urolonc.2022.11.008
Grivas, Petros; Bismar, Tarek A; Alva, Aijai S; Huang, Huei-Chung; Liu, Yang; Seiler, Roland; Alimohamed, Nimira; Cheng, Liang; Hyndman, M Eric; Dabbas, Bashar; Black, Peter C; Davicioni, Elai; Wright, Jonathan L; Ornstein, Moshe C; Mian, Omar Y; Kaimakliotis, Hristos Z; Gibb, Ewan A; Lotan, Yair (2020). Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy. Urologic oncology, 38(4), pp. 262-268. Elsevier 10.1016/j.urolonc.2019.11.004
Batista da Costa, José; Gibb, Ewan A; Bivalacqua, Trinity J; Liu, Yang; Oo, Htoo Zarni; Miyamoto, David T; Alshalalfa, Mohammed; Davicioni, Elai; Wright, Jonathan; Dall'Era, Marc A; Douglas, James; Boormans, Joost L; Van der Heijden, Michiel S; Wu, Chin-Lee; van Rhijn, Bas W G; Gupta, Shilpa; Grivas, Petros; Mouw, Kent W; Murugan, Paari; Fazli, Ladan; ... (2019). Molecular Characterization of Neuroendocrine-like Bladder Cancer. Clinical cancer research, 25(13), pp. 3908-3920. American Association for Cancer Research 10.1158/1078-0432.CCR-18-3558
Hermans, Tom J N; Voskuilen, Charlotte S; van der Heijden, Michiel S; Schmitz-Dräger, Bernd J; Kassouf, Wassim; Seiler, Roland; Kamat, Ashish M; Grivas, Petros; Kiltie, Anne E; Black, Peter C; van Rhijn, Bas W G (2018). Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future. Urologic oncology - seminars and original investigations, 36(9), pp. 413-422. Elsevier 10.1016/j.urolonc.2017.10.014
